当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析 - 资产负债表

联环药业

(600513)

  

流通市值:25.26亿  总市值:25.26亿
流通股本:2.85亿   总股本:2.85亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金281,380,436.24204,433,472.25210,638,608.35253,867,261.69
应收票据及应收账款488,615,601.43479,748,995.65485,316,307.82461,885,825.7
应收账款488,615,601.43479,748,995.65485,316,307.82461,885,825.7
应收款项融资97,015,296.7108,023,611.9103,922,684.0673,920,191.99
预付款项140,229,677.37183,800,433.69188,497,215.26216,179,732.4
其他应收款合计9,812,539.848,450,361.1411,744,847.8711,631,683.66
存货315,447,840.27337,837,382.05326,228,045.82303,334,956.31
其他流动资产20,901,619.3217,611,458.4316,181,072.918,949,613.12
流动资产平衡项目0000
流动资产合计1,353,403,011.171,339,905,715.111,342,528,782.091,329,769,264.87
非流动资产:
长期股权投资11,636,901.8610,523,988.122,261,374.092,630,956.6
投资性房地产7,235,305.811,952,368.341,978,634.832,004,901.24
固定资产1,054,486,132.281,051,721,732.281,058,314,999.541,066,487,733.66
在建工程225,807,814.58169,332,636137,666,184.7397,941,633.61
使用权资产4,543,371.22122,165.88146,599.04-
无形资产101,320,056.8197,674,198.1190,137,558.3587,112,422.49
开发支出37,652,025.6134,107,141.8941,112,713.6538,337,240.41
商誉21,071,947.2921,071,947.2921,071,947.2921,071,947.29
长期待摊费用3,721,885.332,430,384.962,775,123.323,023,189.64
递延所得税资产23,335,308.219,505,801.2920,778,102.6320,985,596.29
其他非流动资产11,488,553.6157,119,532.7437,380,632.7837,579,699.84
非流动资产平衡项目0000
非流动资产合计1,502,299,302.61,465,561,896.91,413,623,870.251,377,175,321.07
资产平衡项目0000
资产总计2,855,702,313.772,805,467,612.012,756,152,652.342,706,944,585.94
流动负债:
短期借款591,762,392.08562,090,035.34541,923,998.62535,784,623.28
应付票据及应付账款263,382,136.35237,968,952.11251,699,051.38250,761,912.85
其中:应付票据82,066,470.1679,049,545.5875,242,391.02103,968,791.35
应付账款181,315,666.19158,919,406.53176,456,660.36146,793,121.5
预收款项138,500,000148,525,829125,025,829125,025,829
合同负债27,132,712.6151,163,085.2852,292,994.2436,663,912.09
应付职工薪酬22,277,460.688,970,748.9311,656,742.269,197,101.93
应交税费33,538,031.419,623,134.3422,888,026.8319,797,752.52
其他应付款合计130,424,399.11159,797,879.16189,768,873.1159,980,939.28
应付股利116,400116,40016,424,177.4116,400
一年内到期的非流动负债31,107,189.5850,015,150.6551,182,136.248,807,986.3
其他流动负债8,397,062.7921,632,828.1915,293,124.1114,105,216.62
流动负债平衡项目0000
流动负债合计1,246,521,384.61,259,787,6431,261,730,775.741,200,125,273.87
非流动负债:
长期借款79,000,00070,000,00049,000,00049,650,000
租赁负债3,912,393.25---
长期应付款592,500367,500367,500367,500
递延收益3,933,557.384,006,561.344,093,364.442,277,647.5
递延所得税负债4,432,215.244,543,645.684,497,8424,870,079.37
非流动负债平衡项目0000
非流动负债合计91,870,665.8778,917,707.0257,958,706.4457,165,226.87
负债平衡项目0000
负债合计1,338,392,050.471,338,705,350.021,319,689,482.181,257,290,500.74
所有者权益(或股东权益):
实收资本(或股本)285,456,270287,145,674287,145,674287,145,674
资本公积259,941,627.72264,511,465.54267,107,365.64269,802,178.08
减:库存股-6,259,242.426,259,242.426,512,652.42
其他综合收益-195,308.71---
盈余公积96,721,894.0483,700,440.8983,700,440.8983,700,440.89
未分配利润712,264,594.45679,119,334.43651,805,299.1664,469,311.56
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,354,189,077.51,308,217,672.441,283,499,537.211,298,604,952.11
少数股东权益163,121,185.8158,544,589.55152,963,632.95151,049,133.09
股东权益平衡项目0000
股东权益合计1,517,310,263.31,466,762,261.991,436,463,170.161,449,654,085.2
负债和股东权益合计2,855,702,313.772,805,467,612.012,756,152,652.342,706,944,585.94
公告日期2024-03-062023-10-312023-08-262023-04-29
审计意见(境内)标准无保留意见
TOP↑